The Stanford Blood and Marrow Transplantation and Cellular Therapy Symposium is a two day hybrid activity. Given the ever-expanding patient population and diagnoses considered for Hematopoietic Cell Transplantation (HCT) and Cellular therapies as well as the complex supportive care required- there is an ongoing need for education of our colleagues that refer and care for these patients prior to and after these therapies. In addition to reviewing the state-of-the-art transplant and cellular therapy-related treatments for hematologic and select nonhematologic diseases--- emphasis will also be placed on the approach to the unique, older patient population considered for these therapies.

Registration

Registration fee includes course materials, certificate of participation, breakfast and lunch.  The symposium is a hybrid activity; you can attend in person or virtually.  Please select the corresponding registration type when registering.

Early Bird Rate: 
Physicians (in person) - $250 
Physicians (virtual) - $250 
Nurses/Allied Health Professionals (in person) - $200 
Nurses/Allied Health Professionals (virtual) - $200
Industry (in person) - $300
Industry (virtual) - $300

After 3/4/2024
Physicians (in person) - $300 
Physicians (virtual) - $300
Nurses/Allied Health Professionals (in person) - $250 
Nurses/Allied Health Professionals (virtual) - $250
Industry (in person) - $350
Industry (virtual) - $350

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator.

Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently. 

Credits

AMA PRA Category 1 Credits™ (13.50 hours), Non-Physician Participation Credit (13.50 hours), ABIM MOC Part 2 (13.50 hours), ANCC Contact Hours (13.50 hours)

Target Audience

Specialties - Hematology, Hematology, Medical Oncology, Oncology
Professions - Advance Practice Nurse (APN), Fellow/Resident, Non-Physician, Nurse, Pharmacist, Physician, Registered Nurse (RN), Social Worker

Objectives

At the conclusion of this activity, learners should be able to: 

• Discuss the importance of stem cell niche in allogeneic hematopoietic cell engraftment.
• Examine how to find suitable allogeneic donor(s) for all patients.
• Interpret the role of regulatory T cells (Treg) in graft-versus-host disease.
• Analyze the novel concept of graft engineering in improving clinical outcomes in allogeneic transplant.
• Review the application of cellular therapy in managing autoimmune disease and inducing tolerance.
• Review the state-of-art report on the utility of CART cells in B-cell malignancies.
• Discuss the development of CART cell therapy in myeloid malignancies.
• Examine the utility of CART cell therapy in solid tumor including sarcoma.

Review the principles and applications of Bone Marrow Transplant (BMT) and Cellular Therapies specifically for the treatment of hematologic malignancy, including lymphoma, leukemias and plasma cell dyscrasia. Analyze the challenges associated with Aging in the context of BMT and Cellular therapies. Examine the role of Cellular Therapies in the treatment of non-hematologic diseases. Explore the use of Cellular Therapy, as well as molecular markers of disease in the pre and post BMT and cell therapies.

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 13.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Live Activity for a maximum of 13.00 ANCC contact hours.  

American Board of Internal Medicine MOC Credit 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MOC Participation Threshold
Learner writes a reflective statement on making a commitment to change or maintaining an element of practice. Validity of all written statements will be assessed prior to awarding credit.